CCND1 and T-cell non-Hodgkin lymphoma: Much evidence have pointed the involvement of cyclins D1 and D3 in T-cell lymphomagenesis, and they have been highlighted as relevant molecular markers of oncogenic power in T cell lymphomas (38, 39).